Seer Inc (SEER)
1.89
-0.05
(-2.58%)
USD |
NASDAQ |
Mar 28, 16:00
1.885
0.00 (0.00%)
After-Hours: 20:00
Seer Cash from Financing (TTM): 0.452M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.452M |
September 30, 2023 | 2.376M |
June 30, 2023 | 2.517M |
March 31, 2023 | 3.171M |
December 31, 2022 | 3.893M |
September 30, 2022 | 3.056M |
June 30, 2022 | 3.496M |
Date | Value |
---|---|
March 31, 2022 | 2.219M |
December 31, 2021 | 116.63M |
September 30, 2021 | 431.46M |
June 30, 2021 | 431.20M |
March 31, 2021 | 486.61M |
December 31, 2020 | 371.49M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.452M
Minimum
Dec 2023
486.61M
Maximum
Mar 2021
142.97M
Average
3.496M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
CEL-SCI Corp | 8.678M |
AIM ImmunoTech Inc | 0.338M |
IGC Pharma Inc | 2.856M |
NovaBay Pharmaceuticals Inc | 4.971M |
Protalix BioTherapeutics Inc | 24.67M |